the aid library

LIST OPTIONS

Filter

4138

Sort by:

Direction:

Download (2014)

View PDF (1466)

Clinic Supervisor Manual

Management Sciences for Health; USAID (2006) C1

This Clinic Supervisor’s Manual is helpful for focusing managers on the key elements of integrated primary health care as they simultaneously integrate new interventions for HIV/AIDS, tuberculosis, and malaria. This tool contains 12 sections. Section 1 explains how to use the manual. Section 2 hel... more

Download (782)

View PDF (2292)

Non communicable diseases kit 2016 (NCDK)

WHO Regional Office for the Eastern Mediterranean (2017) C_WHO

WHO has developed a new health kit to support treatment for chronic disease patients in emergency settings. The prevalence of NCDs is increasing worldwide, including in emergency/crisis-prone areas. Yet current humanitarian response has not accounted for this emerging burden. The NCD kit attends to ... more

Download (998)

View PDF (1831)

Nigeria: National Guideline for the Control and Management of Sickle Cell Disease

Federal Ministry of Health, Nigeria (2014) C1

Download (614)

View PDF (5569)

Best practices for including persons with disabilities in all aspects of developmennt efforts
recommended

United Nations (2011) C2

Download (222)

View PDF (367)

Young Children with Special Needs - Training for early childhood caregivers and teachers

Catholic Relief Services (CRS) & Hilton Foundation (2016) C1

MODULE 5 RESOURCE GUIDE | This guide is part of a series of manuals that focuses on six topics in Early Childhood Development (ECD): different programming approaches, basic concepts, assessments, early childhood environments, children with special needs and child protection, and the health, safety a... more

Download (987)

View PDF (2367)

The Minimum Standards for Age and Disability Inclusion in Humanitarian Action
recommended

ADCAP Age & Disability Capacity; USAID; UKAid; IFRC; et al. Help Age International (2015) CC

The Minimum Standards for Age and Disability Inclusion in Humanitarian Action inform the design, implementation, monitoring and evaluation of humanitarian programmes across all sectors and phases of response, and in all emergency contexts, ensuring older people and people with disabilities are not e... more

Download (280)

View PDF (642)

Epilepsy in the WHO african region: Bridging the Gap

World Health Organization; International League against Epilepsy; International Bureau for Epilepsy (2002) C_WHO

The Global Campaign Against Epilepsy “Out of the Shadows”

Download (1218)

View PDF (1692)

World Health Organization model list of essential medicines for children: 8th list
recommended

World Health Organization WHO (2021) C_WHO

WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable throughout health systems. The updated Essential Medicines List adds 23 medicines for children.

Download (612)

View PDF (751)

World Health Organization Model List of Essential Medicines 22st List
recommended

World Health Organization WHO (2021) C_WHO

WHO today published the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children, which include new treatments for various cancers, insulin analogues and new oral medicines for diabetes, new medicines to assist people who want to stop smoking, and new antimicrobials... more

Download (562)

View PDF (1291)

Integrating palliative care and symptom relief into primary health care : WHO guide for planners, implementers and managers

World Health Organization WHO (2018) C_WHO

Inequality of access to palliative care and symptom relief is one of the greatest disparities in global health care (1). Currently, there is avoidable suffering on a massive scale due to lack of access to palliative care and symptom relief in low- and middle-income countries (LMICs) (1). Yet basic p... more

Download (374)

View PDF (827)

Integrating palliative care and symptom relief into responses to humanitarian emergencies and crises: a WHO guide

World Health Organization WHO (2018) C_WHO

Humanitarian emergencies and crises (Humanitarian emergencies and crises) are large-scale events that may result in the breakdown of health care systems and society, forced displacement, death, and physical, psychological, social and spiritual suffering on a massive scale. Current responses to Human... more

Download (356)

View PDF (956)

Assistance to Victims of Landmines and Explosive Remnants of War: Guidance on Child-focused Victim Assistance. Chapter 5.2 Emergency and continuing medical care

UN Children's Fund UNICEF (2014)

Download (435)

View PDF (580)

Community Mental Health - Implementation Guidelines
recommended

Christoffel-Blindenmission (CBM) (2010)

Download (286)

View PDF (830)

Integrated National Disability Strategy: White Paper

Office on the Status of Disabled Persons, South Africa (1997) C2

Download (611)

View PDF (1150)

Integrating palliative care and symptom relief into paediatrics: a WHO guide for health-care planners, implementers and managers

World Health Organization WHO (2018) C_WHO

People younger than 20 years comprise 35% of the global population and 40% of the global population of least-developed nations. The number of children - neonates, infants, children, and adolescents up to 19 years of age - who need pediatric palliative care (PPC) each year may be as high as 21 millio... more

Download (83)

View PDF (114)

Don’t Leave Them Alone: The future of the cross-border response in north west Syria

ATAA Humanitarian Relief Association, BINAA for Development, Children Of One world, et al. Save the Children (2021) C1

This report, written by ATAA Humanitarian Relief Association, BINAA for Development, Children Of One world, Hand in Hand for Aid and Development, Horan Foundation, Hurras Network, MARAM Foundation, Orange Organization, Syrian American Medical Society, Save the Children and Shafak Organization, provi... more

Download (143)

View PDF (146)

Global Vaccine Market Report 2022

World Health Organization WHO (2022) C_WHO

The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized ... more

Download (100)

View PDF (124)

Ukrainian Crisis - Situational Analysis 18 Nov 2022

Data Friendly Space Reliefweb OCHA Services (2022) C2

Conflict In early October, Ukrainian forces continued recapturing areas of southern and eastern oblasts, notably Lyman (Donetsk oblast). The liberation of thousands of square kilometres resulted in the grim discovery of two new mass graves in Lyman and Sviatohirsk (containing of 120 civilian bodi... more

Download (165)

View PDF (95)

WHO Tanzania 2022 Annual Report

World Health Organisation (WHO) (2023) C_WHO

The Annual Report summarizes what has been achieved in the year 2022, how WHO supported the country priority, how WHO took the lead in health in bringing together partners to help the country achieve its strategic goals as a result be on track on its commitment on the SDG goals. The report also high... more

Download (239)

View PDF (322)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Best practices for including persons with disabilities in all aspects of developmennt efforts recommended

The Minimum Standards for Age and Disability Inclusion in Humanitarian Action recommended

World Health Organization model list of essential medicines for children: 8th list recommended

World Health Organization Model List of Essential Medicines 22st List recommended

Community Mental Health - Implementation Guidelines recommended

Best practices for including persons with disabilities in all aspects of developmennt efforts
recommended

The Minimum Standards for Age and Disability Inclusion in Humanitarian Action
recommended

World Health Organization model list of essential medicines for children: 8th list
recommended

World Health Organization Model List of Essential Medicines 22st List
recommended

Community Mental Health - Implementation Guidelines
recommended